Khan MZ, Baqi A, Patel K, Weinstock J, Franklin S, Kutalek S Clinical In-Hospital Outcomes of Acute Myocardial Infarction in Patients with Hematological Malignancies , Cureus, 14(1): 2022,e21627
Khan MZ, Weinstock J, Patel K, Franklin S, Naftulin J Clinical Outcomes of Acute Myocardial Infarction in Hematological Cancers , American Heart Association Scientific Sessions, Boston, MA: 2021
Weinstock J Coronary Cameral Fistula Case Presentation , Delaware Valley Echo Society Meeting, Philadelphia, PA: 2021
Marks D, Ho R, Then R, Weinstock JL, Teklemariam E, Kakadia B, Collins J, Andriulli J, Hunter K, Ortman M, Russo AM Real-world experience with implantable loop recorder monitoring to detect subclinical atrial fibrillation in patients with cryptogenic stroke: The value of p wave dispersion in predicting arrhythmia occurrence , Int J Cardiol
, 15(327): 2021,86-92
Roy S, Hyman D, Ayyala S, Bakhshi A, Kim SH, Anoruo N, Weinstock J, Balogun A, D'Souza M, Filatova N, Penabad J, Shah Pratik, Perez C, Mehta A, Hunter K Cognitive Function Assessment in Patients on Moderate- or High-Intensity Statin Therapy , J Clin Med Res, 12(4): 2020,255-265
Perz A, Makar G, Fernandez E, Weinstock J, Rafferty W Primary cutaneous mucormycosis of the abdomen at the site of repeated insulin injections , BMJ Case Rep, 13(2): 2020,e33284
Weinstock J Cases of Exertional Dyspnea: How to Sort Out HFpEF and Pulmonary Hypertension , CHEST Annual Meeting, New Orleans, LA
: 2019
Weinstock JL, Marks D, Andriulli JA, Collins J, Ortman ML, Russo AM Subclinical Atrial Fibrillation Identified in the Setting of Cryptogenic Stroke: A Real-World Experience , Heart Rhythm Society 39th Annual Scientific Sessions: 2018
Schreyer E, Kroll C, Plachta K, Luthra P, Weinstock J, et al Implementation of “Choosing Wisely” guidelines for inflammatory markers , Camden Scholars Forum April 2018, Camden, NJ: 2018
Roy S, Weinstock JL, Ishino AS, Benites JF, Samantha SR, Perez CD, Gumbs EA, Rosenbaum JA, Roccato MK, Shah H, Contino G, Hunter K Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors , J Clin Med Res, 9(7): 2017,638-649